Skip to main content
. 2017 Mar 1;24(3):312–326. doi: 10.5551/jat.35592

Table 1. The clinical characteristics of the study subjects.

controls
(n = 23)
type 1 diabetes
(n = 105)
p
Age (years) 34.7 ± 6.2 37.4 ± 12.4 NS
female n (%) 8 (34.8) 71 (65.7) 0.006
duration of diabetes (years) 21.9 ± 9.2
Smoking n (%) 2 (8.7) 35 (34.0) 0.016
BMI (kg/m2) 20.6 ± 2.6 23.0 ± 3.0 <0.001
Systolic BP (mmHg) 114 ± 7 117 ± 14 NS
Diastolic BP (mmHg) 68.9 ± 5.9 69.7 ± 9.2 NS
AST (U/L) 18.5 ± 4.0 18.4 ± 5.5 NS
ALT (U/L) 14.9 ± 6.2 15.4 ± 9.3 NS
GGT (U/L) 20.1 ± 9.6 24.4 ± 36.7 NS
Glucose (mg/dL) 92.8 ± 8.3 156.7 ± 75.0 <0.001
HbA1c (%) 5.1 ± 0.2 7.7 ± 1.4 <0.001
GA (%) 13.8 ± 1.1 23.5 ± 5.0 <0.001
TC (mg/dL) 181.8 ± 23.9 186.6 ± 32.2 NS
TG (mg/dL) 59 (30–623) 66 (21–757) NS*
HDL-C (mg/dL) 62.8 ± 13.1 67.3 ± 13.2 NS
LDL-C (mg/dL) 104.1 ± 22.1 102.6 ± 26.8 NS
UA (mg/dL) 5.2 ± 1.5 4.4 ± 1.3 0.012
Creatinine (mg/dL) 0.82 ± 0.16 0.71 ± 0.17 0.005
eGFR (ml/min/1.73 m2) 81.4 ± 11.3 87.5 ± 17.2 NS
UACR (mg/g/Cr) 45.3 ± 320
CVR-R (%) 5.47 ± 2.71 3.94 ± 1.84 0.001
Nephropathy (no n (%)) 95 (91.3)
Retinopathy (no n (%)) 58 (59.2)
maxIMT (mm) 0.76 ± 0.21 1.09 ± 0.48 0.002
ABI 1.07 ± 0.08 1.07 ± 0.08 NS
ba-PWV (cm/sec) 1225 ± 156 1318 ± 248 NS
Skin AF (AU) 1.90 ± 0.26 2.07 ± 0.50 0.024

Data are expressed as mean ± SD, median (range), or number and percentage. Unpaired t-test, Welch's t-test or the *Mann-Whitney U test was performed. P-value <0.05 was considered statistically significant.

Abbreviations: BMI, body mass index; BP, blood pressure; AST, aspartate transaminase; ALT, alanine transaminase; GGT, κ-glutamyltransferase; HbA1c, glycated hemoglobin A1c; GA, glycoalbumin; TC, total cholesterol; TG, serum triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UA, uric acid; eGFR, estimated glomerular filtration rate; UACR, urinary albumin-to-creatinine ratio; CVR-R, coefficient of variation of R-R intervals; IMT, intima media thickness; ABI, ankle-brachial index; PWV, pulse wave verbosity.